These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Acquired von Willebrand syndrome: data from an international registry. Federici AB, Rand JH, Bucciarelli P, Budde U, van Genderen PJ, Mohri H, Meyer D, Rodeghiero F, Sadler JE, Subcommittee on von Willebrand Factor. Thromb Haemost; 2000 Aug; 84(2):345-9. PubMed ID: 10959711 [Abstract] [Full Text] [Related]
3. Diagnosis and management of acquired von Willebrand syndrome. Federici AB, Mannucci PM. Clin Adv Hematol Oncol; 2003 Mar; 1(3):169-75. PubMed ID: 16224398 [Abstract] [Full Text] [Related]
4. Use of intravenous immunoglobulin in patients with acquired von Willebrand syndrome. Federici AB. Hum Immunol; 2005 Apr; 66(4):422-30. PubMed ID: 15866707 [Abstract] [Full Text] [Related]
7. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Federici AB. Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386 [Abstract] [Full Text] [Related]
8. Pharmacokinetic studies with FVIII/von Willebrand factor concentrate can be a diagnostic tool to distinguish between subgroups of patients with acquired von Willebrand syndrome. Luboshitz J, Lubetsky A, Schliamser L, Kotler A, Tamarin I, Inbal A. Thromb Haemost; 2001 May; 85(5):806-9. PubMed ID: 11372672 [Abstract] [Full Text] [Related]
9. Acquired von Willebrand syndrome 2004: International Registry--diagnosis and management from online to bedside. Federici AB, Budde U, Rand JH. Hamostaseologie; 2004 Feb; 24(1):50-5. PubMed ID: 15029273 [Abstract] [Full Text] [Related]
18. Current diagnostic and therapeutic approaches to patients with acquired von Willebrand syndrome: a 2013 update. Federici AB, Budde U, Castaman G, Rand JH, Tiede A. Semin Thromb Hemost; 2013 Mar; 39(2):191-201. PubMed ID: 23397553 [Abstract] [Full Text] [Related]